Phase2 study of itraconazole,abraxane, carboplatin and avastin for advanced nonsquamous nonsmall cell lung cancer
Latest Information Update: 06 Oct 2015
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary) ; Carboplatin; Itraconazole
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 06 Oct 2015 New trial record